Real-time enrollment status for this lung cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:17 AM UTC
| NCT Number | NCT04614103 |
| Recruiting Status | Recruiting |
| Condition | Lung Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 170 participants |
| Active Locations | 44 sites in the US |
| Sponsor | Iovance Biotherapeutics, Inc. |
| Last Updated on CT.gov | November 12, 2025 (Nov 12, 2025) |
As of March 2, 2026: Clinical trial NCT04614103 is currently recruiting participants. This clinical trial study for lung cancer is actively seeking new participants at 44 locations across the United States. The study is sponsored by Iovance Biotherapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04614103 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 44 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04614103 was last updated Nov 12, 2025 (November 12, 2025). HelloStudys verifies this status automatically.